Humans are potentially exposed to phthalate esters (PEs) through ingestion, inhalation, and dermal contact. Studies quantifying exposure to PEs include “biomarker studies” and “indirect studies.” Biomarker studies use measurements of PE metabolites in urine to back-calculate exposure to the parent diester, while indirect studies use the concentration of the PE in each medium of exposure and the rate of intake of that medium to quantify intake of the PE. In this review, exposure estimates from biomarker and indirect studies are compiled and compared for seven PEs to determine if there are regional differences and if there is a preferred approach. The indirect and biomarker methods generally agree with each other within an order of magnitude and discrepancies are explained by difficulties in accounting for use of consumer products, uncertainty concerning absorption, regional differences, and temporal changes. No single method is preferred for estimating intake of all PEs; it is suggested that biomarker estimates be used for low molecular weight PEs for which it is difficult to quantify all sources of exposure and either indirect or biomarker methods be used for higher molecular weight PEs. The indirect methods are useful in identifying sources of exposure while the biomarker methods quantify exposure.

No abstract

Abstract-In whole effluent toxicity tests, organisms are exposed to various effluent concentrations for a specific time period to estimate the potential effects of an effluent on a receiving stream. Laboratories typically have good success performing valid chronic toxicity tests. However, some difficulty in conducting valid chronic whole effluent toxicity tests with Pimephales promelas (fathead minnow) has been encountered as a result of sporadic control mortality. Some investigators report an interference that causes anomalous patterns of survival in chronic fathead minnow tests. This interference has been termed sporadic mortality phenomenon. Characteristics of sporadic mortality phenomenon include high variability among replicates, nonmonotonic dose responses, mortality beginning on or about day 4 of the test, and fungal growths often observed on the larvae. Histopathologic examinations often indicate bacterial and/or fungal infections on fish exhibiting symptoms of sporadic mortality phenomenon. The most plausible explanation of sporadic mortality phenomenon is a naturally occurring pathogen or pathogens that interfere with the test method. This interference may invalidate tests or falsely indicate toxicity. Sporadic mortality phenomenon can be reduced or eliminated by sample treatments intended to inactivate (heating, antibiotics, or ultraviolet light) or remove (filtration) pathogenic microorganisms. These methods must be used with forethought because of their potential to alter the toxicity of a sample.